A detailed history of North Star Investment Management Corp. transactions in Renalytix PLC stock. As of the latest transaction made, North Star Investment Management Corp. holds 43,000 shares of RNLX stock, worth $6,450. This represents 0.0% of its overall portfolio holdings.

Number of Shares
43,000
Previous 43,000 -0.0%
Holding current value
$6,450
Previous $9,000 -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 30, 2024

BUY
$0.26 - $1.47 $3,120 - $17,640
12,000 Added 38.71%
43,000 $36,000
Q2 2023

Aug 02, 2023

BUY
$2.0 - $2.92 $10,000 - $14,600
5,000 Added 19.23%
31,000 $90,000
Q4 2022

Jan 11, 2023

BUY
$1.06 - $2.21 $8,480 - $17,680
8,000 Added 44.44%
26,000 $0
Q3 2022

Nov 02, 2022

BUY
$1.19 - $2.78 $15,470 - $36,140
13,000 Added 260.0%
18,000 $23,000
Q1 2022

May 03, 2022

BUY
$5.88 - $15.9 $29,400 - $79,500
5,000 New
5,000 $35,000

Others Institutions Holding RNLX

About Renalytix plc


  • Ticker RNLX
  • Exchange OTC
  • Sector Healthcare
  • Industry Health Information Services
  • Shares Outstandng 37,445,900
  • Market Cap $5.62M
  • Description
  • Renalytix Plc develops artificial intelligence-enabled in vitro diagnostic solutions for kidney diseases. The company offers KidneyIntelX, a diagnostic platform that employs an artificial intelligence-enabled algorithm that combines various data inputs, including validated blood-based biomarkers, inherited genetics and personalized patient data ...
More about RNLX
Track This Portfolio

Track North Star Investment Management Corp. Portfolio

Follow North Star Investment Management Corp. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of North Star Investment Management Corp., based on Form 13F filings with the SEC.

News

Stay updated on North Star Investment Management Corp. with notifications on news.